Alexander Shtabsky

Dr. Alexander Shtabsky

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
GHGil Hecht
Gil Hecht
SESmadar Eventov-Friedman
Smadar Eventov-Friedman
CRChava Rosen
Chava Rosen
ESElias Shezen
Elias Shezen
DTDalit Tchorsh
Dalit Tchorsh
YRYair Reisner
Yair Reisner
Xenotransplantation of pig tissues has great potential to overcome the shortage of organ donors. One approach to address the vigorous immune rejection associated with xenotransplants is the use of embryonic precursor tissue, which induces and utilizes host vasculature upon its growth and development. Recently, we showed in mice that embryonic pig pancreatic tissue from embryonic day 42 (E42) exhibits optimal properties as a β cell replacement therapy. We now demonstrate the proof of concept in 2 diabetic Cynomolgus monkeys, followed for 393 and 280 days, respectively. A marked reduction of exogenous insulin requirement was noted by the fourth month after transplantation, reaching complete independence from exogenous insulin during the fifth month after transplantation, with full physiological control of blood glucose levels. The porcine origin of insulin was documented by a radioimmunoassay specific for porcine C-peptide. Furthermore, the growing tissue was found to be predominantly vascularized with host blood vessels, thereby evading hyperacute or acute rejection, which could potentially be mediated by preexisting anti-pig antibodies. Durable graft protection was achieved, and most of the late complications could be attributed to the immunosuppressive protocol. While fine tuning of immune suppression, tissue dose, and implantation techniques are still required, our results demonstrate that porcine E-42 embryonic pancreatic tissue can normalize blood glucose levels in primates. Its long-term proliferative capacity, its revascularization by host endothelium, and its reduced immunogenicity, strongly suggest that this approach could offer an attractive replacement therapy for diabetes.

1 October 2008 in Cytokine
Verified
Journal Article
Closed access
GSGali Soria
Gali Soria
NYNeora Yaal-Hahoshen
Neora Yaal-Hahoshen
EAElina Azenshtein
Elina Azenshtein
SSSima Shina
Sima Shina
LLLeonor Leider-Trejo
Leonor Leider-Trejo
ABAdit Ben-Baruch
Adit Ben-Baruch

1 April 2009 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
RLRoee Landsberg
Roee Landsberg
ADAri DeRowe
Ari DeRowe
AKAbraham Katzir
Abraham Katzir
ASAlexander Shtabsky
Alexander Shtabsky
DFDan M. Fliss
Dan M. Fliss
Ziv GilZiv Gil
Ziv Gil

17 April 2007 in The Prostate
Verified
Journal Article
Closed access
PDF file
RBRami Ben‐Yosef
Rami Ben‐Yosef
ASAlex Starr
Alex Starr
VKVictoria Karaush
Victoria Karaush
VLVered Loew
Vered Loew
SLShahar Lev‐Ari
Shahar Lev‐Ari
AVAkiva Vexler
Akiva Vexler

1 March 2008 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
PDF file
RRRan Reshef
Ran Reshef
DSDoron Schwartz
Doron Schwartz
MIMerav Ingbir
Merav Ingbir
ASAlexander Shtabsky
Alexander Shtabsky
TCTamara Chernichovski
Tamara Chernichovski
ISIdit F. Schwartz
Idit F. Schwartz
While a specific role for nitric oxide (NO) in inducing the hemodynamic alterations of pregnancy is somewhat controversial, it is widely accepted that excess NO is generated during pregnancy. l-Arginine is the sole precursor for NO biosynthesis. Among several transporters that mediate l-arginine uptake, cationic amino acid transporter-1 (CAT-1) acts as the specific arginine transporter for endothelial NO synthase. The present study was designed to test the hypothesis that, during pregnancy, when arginine consumption by the fetus is significantly increased, compensatory changes in maternal arginine uptake affect the endothelium. Uptake of radiolabeled arginine (l-[3H]arginine) by freshly harvested maternal aortic rings from pregnant rats decreased by 65 and 30% in mid- and late pregnancy, respectively, compared with those obtained from virgin animals. This decrease was associated with a significant increase in endothelial protein nitration (the footprint of peroxynitrite generation), as shown by both Western blotting and immunohistochemistry utilizing anti-nitrotyrosine antibodies, reflecting endothelial damage. Northern blot analysis revealed that steady-state aortic CAT-1 mRNA levels did not change throughout pregnancy, whereas CAT-1 protein abundance was significantly increased, peaking at mid-pregnancy. Protein content of protein kinase C (PKC)-α, which was previously shown to decrease CAT-1 activity, increased significantly in the pregnant animals and was associated with a significant increase in CAT-1 phosphorylation. Intraperitoneal injection of α-tocopherol, a PKC-α inhibitor, prevented the decrease in arginine transport and attenuated protein nitration. In conclusion, aortic arginine uptake is reduced during pregnancy, through posttranslational modulation of CAT-1 protein, presumably via upregulation of PKC-α. The aforementioned findings are associated with an increase in protein nitration and, therefore, in selected individuals, may lead to the development of certain forms of endothelial dysfunction, like preeclampsia.

13 March 2008 in Stem Cells
Verified
Journal Article
Open access
PDF file
HKHelena Katchman
Helena Katchman
OTOrna Tal
Orna Tal
SESmadar Eventov-Friedman
Smadar Eventov-Friedman
ESElias Shezen
Elias Shezen
AAAnna Aronovich
Anna Aronovich
YRYair Reisner
Yair Reisner
Cell therapy as an alternative to orthotopic liver transplantation represents a major challenge, since negligible proliferation of isolated hepatocytes occurs after transplantation because of the stringent homeostatic control displayed by the host liver. Thus, different modalities of liver injury as part of the pretransplant conditioning are a prerequisite for this approach. The major objective of the present study was to test whether xenotransplantation of pig fetal liver fragments, in which potential cell-cell and cell-stroma interactions are spared, might afford more robust growth and proliferation compared with isolated pig fetal hepatoblasts. After transplantation into SCID mice, fetal liver tissue fragments exhibited marked growth and proliferation, in the setting of a quiescent host liver, compared with isolated fetal hepatoblasts harvested at the same gestational age (embryonic day 28). The proliferative advantage of fetal pig liver fragments was clearly demonstrated by immunohistochemical and morphometric assays and was observed not only after implantation into the liver but also into extrahepatic sites, such as the spleen and the subrenal capsule. The presence of all types of nonparenchymal liver cells that is crucial for normal liver development and regeneration was demonstrated in the implants. Preservation of the three-dimensional structure in pig fetal liver fragments enables autonomous proliferation of transplanted hepatic cells in the setting of a quiescent host liver, without any requirement for liver injury in the pretransplant conditioning. The marked proliferation and functional maturation exhibited by the pig fetal liver fragments suggests that it could afford a preferable source for transplantation. Disclosure of potential conflicts of interest is found at the end of this article.